Community-Acquired Pneumonia (CAP) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 Community-acquired pneumonia (CAP) denotes an acute infection affecting the pulmonary parenchyma in individuals devoid of recent hospitalization within 14 days and not residing in nursing homes or long-term care facilities. The etiology of CAP encompasses two broad categories: Typical agents (e.g., Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, Group A Streptococci, anaerobes, and gram-negative organisms) and Atypical agents (e.g., Legionella, Mycoplasma, Chlamydia pneumoniae, and C. psittaci), with H. influenzae and S. pneumoniae commonly implicated as bacterial causative agents. Pharyngeal colonization by pathogens, followed by micro-aspiration, constitutes the primary mechanism of lower respiratory tract invasion, supplemented by hematogenous dissemination and macro-aspiration. Pneumonia manifests when host pulmonary defenses are compromised or overwhelmed by a substantial pathogen inoculum or virulence. Risk factors for CAP encompass advancing age, chronic comorbidities, notably chronic obstructive pulmonary disease (COPD), chronic lung diseases (e.g., bronchiectasis, asthma), chronic heart diseases (particularly congestive heart failure), stroke, diabetes mellitus, malnutrition, and immunocompromising conditions. Viral respiratory tract infections, especially influenza, predispose individuals to primary viral pneumonia and secondary bacterial pneumonia. Impaired airway protection, exemplified by conditions fostering microaspiration of gastric contents or microaspiration of upper airway secretions (e.g., altered consciousness, dysphagia), heightens CAP susceptibility. Modifiable behavioral risk factors include smoking, excessive alcohol consumption, and opioid use. In contrast, socio-environmental factors such as crowded living conditions, low-income settings, and exposure to environmental toxins also contribute to increased CAP risk. The therapeutic approach for outpatient CAP typically involves monotherapy with a macrolide (e.g., erythromycin, azithromycin, or clarithromycin) or doxycycline. However, in the presence of comorbidities such as chronic heart disease (excluding hypertension), chronic lung disease (including COPD and asthma), chronic liver disease, chronic alcohol use disorder, diabetes mellitus, smoking, splenectomy, human immunodeficiency virus (or other forms of immunosuppression), a respiratory fluoroquinolone (e.g., high-dose levofloxacin, moxifloxacin, gemifloxacin) or a combination of oral beta-lactam (e.g., high-dose amoxicillin or amoxicillin-clavulanate, cefuroxime, cefpodoxime) and macrolide is recommended.

 

Thelansis’s “Community-Acquired Pneumonia (CAP) Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Community-Acquired Pneumonia (CAP) treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Community-Acquired Pneumonia (CAP) across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Community-Acquired Pneumonia (CAP) Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Community-Acquired Pneumonia (CAP) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Community-Acquired Pneumonia (CAP), Community-Acquired Pneumonia (CAP) market outlook, Community-Acquired Pneumonia (CAP) competitive landscape, Community-Acquired Pneumonia (CAP) market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more